Johnson & Johnson (JNJ) reported Q2 FY 2019 earnings of $2.58 per share (versus $2.10 in Q2 FY 2018), beating analysts’ consensus of $2.44.
The company’s quarterly revenues amounted to $20.562 bln (-1.3% y/y), generally in line with analysts’ consensus estimate of $20.388 bln.
The company also announced it continued to see FY 2019 EPS of $8.53-8.63 (versus analysts’ consensus estimate of $8.62) but raised FY 2019 revenues guidance to $80.8-81.6 bln from prior $80.4-81.2 bln (versus analysts’ consensus estimate of $81.27 bln).
JNJ rose to $135.95 (+0.92%) in pre-market trading.
|remaining time till the new event being published|
All posted material is a marketing communication solely for informational purposes and reliance on this may lead to loss. Past performance is not a reliable indicator of future results. Please read our full disclaimer.